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Abstract. Mannich reaction was applied between 4-fluorobezaldehyde, selected acetophenone and several 
anilines, catalyzed by silica sulfuric acid for the synthesis of β-amino carbonyl derivatives. Reaction time 
and yield of the products depended on the nature of acetophenone and aniline subsituents. Using aliphatic 
amines instead of aromatic amines under same reaction conditions, afforded aldol condensation products 
without yielding the expected β-amino ketones. Replacing the acetophenone derivatives with rhodanine 
yielded 5-(4-fluorobenzylidene)-thioxothiazolidin-4-one. Using 2-aminothiophenol instead of the aniline 
derivatives, 2-(4-fluorophenyl)benzothiazole was obtained without isolation of the expected (mercapto-
phenylamino)-1-(4-substitutedphenyl)propan-1-ones. A proposed reaction mechanism was suggested. 
Docking studies were designed to gain clear picture of the high active compound(s). A model of high ac-
tive molecules was mapped for the antimicrobial screening and compared with least active compound(s). 
(doi: 10.5562/cca1983) 




Fluorine has been reported to exert many pronounced 
effects on the properties of organic compounds when 
employed as a substituent. As a result, in many areas of 
applied organic chemistry, including polymer chemistry 
and biological or medicinal chemistry, fluorinated com-
pounds are attractive synthetic targets and the effects of 
fluorination on structure-activity relationships received 
much scrutiny.1 Moreover, owing to the growing appli-
cations of fluorinated molecules in agro- and pharma-
ceutical chemistry, several groups have proposed new 
multifunctional fluorinated synthons, which are very 
useful as building blocks.2 For example, the initial bio-
logical studies of a new 2'-deoxy-2'-fluoro-2'-C-methyl 
nucleoside analogue that was designed and synthesized 
indicated that this compound showed promising activity 
against hepatitis C virus (HCV) replication.3 
Three-component coupling Mannich reactions are 
among the most important carbon-carbon bond forming 
reactions in organic synthesis.4 These reactions provided 
β-amino carbonyl compounds, which are important 
synthetic intermediates for various pharmaceuticals and 
natural products.5 Therefore, the development of new 
synthetic methods leading to β-amino carbonyl com-
pounds has attracted much attention. Due to the limited 
applications of the classic Mannich reaction, numerous 
versions of this reaction were developed using per-
formed electrophiles, such as imines and stable nucleo-
philes, enolates, enol ethers, and enamines.6 Hence, 
there is high interest in developing convenient methods 
for the synthesis of β-amino ketone nucleus. Some of 
these achievements in the efficient construction of this 
nucleus included the development of Lewis acid cata-
lysts; however, few useful Lewis acid catalysts were 
developed in the past years.7 Also, several one-pot pro-
cedures on the use of unmodified aldehydes or ketones 
were reported with a variety of catalysts such as SDA–
HCl,8−10 PS–SO3H,
11 and chiral Brønsted acid.12,13 
Silica sulfuric acid (SSA) was introduced as a solid 
inorganic acidic proton source catalyst14 by the reaction 
of silica-gel and chlorosulfonic acid for the various func-
tional group transformations.15−22 In addition, many novel 
heterogenized catalysts were based on silica supports 
such as silica sulfuric acid (SSA) due to their high surface 
areas and porosities, excellent stabilities (chemical and 
thermal), and facile functionalization with organic groups 
that can be robustly anchored to the surface.23−25 
Therefore, the present work is intended for apply-
ing a facile and efficient one-pot three-component reac-
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tion between 4-fluorobenzaldehyde, selected aceto-
phenone derivatives and several aniline, catalyzed by 
silica sulfuric acid (SSA) via Mannich reaction in order 
to synthesize new β-amino carbonyl compounds (4) 




Melting points are uncorrected. Microanalyses were 
carried out by the Micro-analytical Laboratory, National 
Research Center, Cairo, Egypt. Infrared spectra (KBr) 
were recorded using a Jasco FT/IR-300E spectropho-
tometer. Analytical TLC was performed with silica-gel 
GF254 plates (petroleum ether / ethyl acetate (4:1 by 
volume), and the products were visualized by UV detec-
tion. Proton and 13C-NMR spectra (500, or 125 Hz; 
whenever reported) were recorded in DMSO-d6. Chemi-
cal shifts (δ) reported in ppm using TMS as internal 
standard and spin-spin coupling constants (J) were giv-
en in Hz. EI-MS spectra were measured on an HP 
5988A spectrometer by direct inlet at 70eV. 
 
Synthesis of Compounds (4a–n) 
General Procedure: A mixture of 4-flourobenzaldehyde 
(2.0 mmol), aniline (2.0 mmol), aromatic ketone (2.0 
mmol), and SSA (0.11 g, 0.04 mol %) was stirred in 
EtOH (5 ml) at room temperature for 6–13 h. The reac-
tion was monitored on TLC. After completion of the 
reaction, CH2Cl2 was added and the catalyst removed by 
filtration. The obtained filtrate washed with saturated 
NaHCO3 (aqueous) and brine, dried over anhydrous 
Na2SO4, filtered and evaporated to dryness under re-
duced pressure. The obtained residue purified by silica-
gel chromatography to obtain compounds (4a–n).  
3-(4-Fluorophenyl)-1-phenyl-3-(phenylamino)propan-1-
one (4a): White solid, yield: 70 %, m.p.: 110−112 °C.26 
Rf = 0.36. IR (KBr) vmax/cm
−1: 3383 (NH), 1667 (C=O). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 3.33−3.55 (m, 
2H, COCH2), 4.60 (b, 1H, NH), 4.96 (t, J = 6.75 Hz, 
1H, NCH), 6.40−8.00 (m, 14H, ArH). MS (EI) m/z (%) 
= 319 (M+, 30.24 %). Anal. Calcd. for C21H18FNO; MW 
= 319.37: C, 78.98; H, 5.68; N, 4.39. Found C, 78.75; 
H, 5.79; N, 4.66 %. 
3-(4-Fluorophenyl)-1-phenyl-3-(4-tolylamino)propan-1-
one (4b): White solid, yield: 68 %, m.p.: 131−132 °C.27 
Rf = 0.36. IR (KBr) vmax/cm
−1: 3377 (NH), 1672 (C=O). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 2.45 (m, 3H, 
CH3), 3.28−3.36 (m, 2H, COCH2), 4.93 (t, J = 6.90 Hz, 
1H, NCH), 5.96 (b, 1H, NH), 6.36−7.91 (m, 13H, ArH). 
MS (EI) m/z = 333 (M+, 24.15 %). Anal. calcd. for 
C22H20FNO; MW = 333.40: C, 79.26; H, 6.05; F, 5.70; 
N, 4.20. Found: C, 79.35; H, 6.44; N, 4.70 %. 
3-(4-Fluorophenyl)-3-(4-fluorophenylamino)-1-
phenylpropan-1-one (4c): White solid, yield: 72 %, 
m.p.: 116−118 °C. Rf = 0.45. IR (KBr) vmax/cm
−1: 3385 
(NH), 1671 (C=O). 1H NMR (500 MHz, DMSO-d6) 
δ/ppm: 3.31−3.50 (m, 2H, COCH2), 4.46 (s, 1H, NH), 
4.90 (t, J = 6.1 Hz, 1H, NCH), 6.40−7.94 (m, 13H, 
ArH). 13C NMR (125 MHz, DMSO-d6), δ/ppm: 197.74 
(CO), 162.56, 160.64, 155.77, 153.92, 144.88, 140.43, 
137.26, 133.74, 129.23, 129.13, 129.07, 128.57, 115.57, 
115.47, 114.14 (ArC, ArCH), 53.40 (CHNH), 46.95 
(CH2). MS (EI) m/z = 337 (M
+, 24.83 %). Anal. Calcd. 
for C21H17F2NO; (MW = 337.36): C, 74.76; H, 5.08; F, 
11.26; N, 4.15. Found: C, 74.96; H, 5.11; N, 4.31 %. 
3-(4-Chlorophenylamino)-3-(4-fluorophenyl)-1-
phenylpropan-1-one (4d): Pale yellow solid, yield: 72 
%, m.p.: 118−120 °C. Rf = 0.50. IR (KBr) vmax/cm
−1: 
3367 (NH), 1662 (C=O). 1H NMR (500 MHz, DMSO-
d6) δ/ppm: 3.30−3.52 (m, 2H, COCH2), 4.45 (b, 1H, 
NH), 4.95 (t, J = 6.1 Hz, 1H, NCH), 6.42−7.96 (m, 13H, 
ArH). 13C NMR (125 MHz, DMSO-d6), δ/ppm: 197.55 
(CO), 162.63, 160.70, 147.16, 140.19, 137.22, 133.74, 
129.22, 129.00, 128.57, 119.85, 115.69, 115.52, 114.77 
(Arc, ArCH), 52.78 (CHNH), 46.86 (CH2) MS (EI) m/z 
= 353 (M+, 31.80 %). Anal. Calcd. for C21H17ClFNO; 
MW = 353.82: C, 71.29; H, 4.84; N, 3.96. Found: C, 
71.44; H, 4.99; N, 3.41 %. 
3-(4-Bromophenylamino)-3-(4-fluorophenyl)-1-
phenylpropan-1-one (4e): White solid, yield: 70 %, 
m.p.: 131−133 °C. Rf = 0.55. IR (KBr) vmax/cm
−1: 3365 
(NH), 1662 (C=O). 1H NMR (500 MHz, DMSO-d6), 
δ/ppm: 3.26−3.58 (m, 2H, COCH2), 4.46 (b, 1H, NH), 
4.93 (m, 1H, NCH), 6.41−7.93 (m, 13H, ArH). MS (EI) 
m/z = 398(M+,15.60 %). Anal. Calcd. for C21H17BrFNO; 
MW = 398.27: C, 63.33; H, 4.30; N, 3.52. Found C, 
63.56; H, 4.88; N, 3.86 %. 
3-(4-Fluorophenyl)-3-(phenylamino)-1-4-tolylpropan-1-
one (4f): White solid, yield: 76 %, m.p.: 92−93 °C. Rf = 
0.41. IR (KBr) vmax/cm
−1: 3369(NH), 1660 (C=O). 1H 
NMR (500 MHz, DMSO-d6), δ/ppm: 2.46 (s, 3H, CH3), 
3.30−3.55 (m, 2H, COCH2), 4.60 (b, 1H, NH), 5.00 (t, J 
= 6.4 Hz, 1H, NCH), 6.46−8.00 (m, 13H, ArH). MS (EI) 
m/z = 333 (M+, 10.22 %). Anal. Calcd. for C22H20FNO; 
MW = 333.40: C, 79.26; H, 6.05; N, 4.20. Found: C, 
79.11; H, 6.54; N, 4.65 %. 
3-(4-Fluorophenyl)-1-p-tolyl-3-(4-tolylamino) propan-
1-one (4g): White solid, yield: 66 %, m.p.: 150−152 °C. 
Rf = 0.39. IR (KBr) vmax/cm
−1: 3357 (NH), 1673 (C=O). 
1H NMR (500 MHz, DMSO-d6), δ/ppm: 2.33 (s, 3H, 
CH3), 2.55 (s, 3H, CH3), 3.20−3.56 (m, 2H, COCH2), 
4.91 (m, 1H, NCH), 5.94 (s, 1H, NH), 6.35−7.82 (m, 
12H, ArH). 13C NMR (125 MHz, DMSO-d6), δ/ppm: 
197.44 (CO), 160.53, 145.86, 144.10, 140.74, 134.81, 
129.72, 129.07, 128.71, 124.89, 121.08, 120.24, 115.52, 
115.36, 113.63 (ArC, ArCH), 53.08 (CHNH), 46.79 
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(CH2), 21.67 (CH3), 20.53 (CH3). MS (EI) m/z = 347 
(M+, 25.24 %). Anal. Calcd. for C23H22FNO; MW = 
347.43: C, 79.51; H, 6.38; N, 4.03. Found: C, 79.88; H, 
6.80; N, 4.35 %. 
3-(4-Fluorophenyl)-3-(4-fluorophenylamino)-1-p-
tolylpropan-1-one (4h): White solid, yield: 66 %, 
m.p.:128−130 °C. Rf = 0.53. IR (KBr) vmax/cm
−1: 3362 
(NH), 1656 (C=O). 1H NMR (500 MHz, DMSO-d6), 
δ/ppm: 2.34 (m, 3H, CH3), 3.30−3.46 (m, 2H, COCH2), 
4.50 (b, 1H, NH), 4.95 (t, J = 6.90 Hz, 1H, NCH), 
6.40−7.89 (m, 12H, ArH). MS (EI) m/z = 351 (M+, 
20.15). Anal. Calcd. for C22H19F2NO; MW = 351.39: C, 
75.20; H, 5.45; N, 3.99. Found: C, 75.42; H, 5.84; N, 
3.72 %. 
1-(4-Chlorophenyl)-3-(4-fluorophenyl)-3-(phenyl-
amino)propan-1-one(4i): White solid, yield: 87 %, m.p.: 
109−111°C. Rf = 0.45. IR (KBr) vmax/cm
−1: 3364(NH), 
1673 (C=O). 1H NMR (500 MHz, DMSO-d6), δ/ppm: 
3.38−3.52 (m, 2H, COCH2), 4.53 (b, 1H, NH), 4.95 (t, 
J=6.75 Hz, 1H, NCH), 6.50−8.00 (m, 13H, ArH). MS 
(EI) m/z = 353 (M+, 6.01). Anal. Calcd. for 
C21H17ClFNO; MW = 353.82: C, 71.29; H, 4.84; N, 
3.96. Found: C, 71.50; H, 4.41; N, 3.80 %. 
1-(4-Chlorophenyl)-3-(4-fluorophenyl)-3-(4-fluoro-
phenylamino)propan-1-one (4j): White solid, yield: 90 
%, m.p.: 80−82 °C. Rf = 0.38. IR (KBr) vmax/cm
−1: 3365 
(NH), 1673 (C=O). 1H NMR (500 MHz, DMSO-d6), 
δ/ppm: 3.35−3.47 (m, 2H, COCH2), 4.40 (s, 1H, NH), 
4.90 (t, J = 6.72 Hz, 1H, NCH), 6.40−7.91 (m, 12H, 
ArH). MS (EI) m/z = 371 (M+, 15.19 %). Anal Calcd. 
for C21H16ClF2NO; MW = 371.81: C, 67.84; H, 4.34; N, 
3.77. Found C, 67.44; H, 4.10; N, 3.89 %. 
1-(4-Bromophenyl)-3-(4-fluorophenyl)-3-(phenyl-
amino)propan-1-one (4k): White solid, yield: 82 %, 
m.p.: 112−114 °C. Rf = 0.45. IR (KBr) vmax/cm
−1: 3365 
(NH), 1673 (C=O). 1H NMR (500 MHz, DMSO-d6), 
δ/ppm: 3.25−3.57 (m, 2H, COCH2), 4.44 (s, 1H, NH), 
4.93 (t, J=6.52 Hz, 1H, NCH), 6.43−7.86 (m, 13H, 
ArH). 13C NMR (125 MHz, DMSO-d6), δ/ppm: 197.05 
(CO), 163.97, 162.55, 148.15, 140.53, 136.26, 132.29, 
130.64, 129.27, 129.04, 127.82, 116.49, 115.62, 115.45, 
113.40 (ArC, ArCH), 52.80 (CHNH), 46.91 (CH2) MS 
(EI) m/z = 398 (M+, 5.54 %). Anal. Calcd. for 
C21H17BrFNO; MW = 398.27: C, 63.33; H, 4.30; N, 
3.52. Found C, 63.77; H, 4.46; N, 3.99 %. 
1-(4-Bromophenyl)-3-(4-fluorophenyl)-3-(4-fluoro-
phenylamino)propan-1-one (4l): White solid, yield: 82 
%, m.p.: 94−96 °C. Rf = 0.50. IR (KBr) vmax/cm
−1: 3362 
(NH), 1675 (C=O). 1H NMR (500 MHz, DMSO-d6), 
δ/ppm: 3.33−3.47 (m, 2H, COCH2), 4.40 (b, 1H, NH), 
4.90 (t, J = 6.1 Hz, 1H, NCH), 6.42−7.78 (m, 12H, 
ArH). MS (EI) m/z = 416 (M+, 15.20 %). Anal. Calcd. 
for C21H16BrF2NO; MW = 416.26: C, 60.59; H, 3.87; N, 
3.36. Found C, 60.33; H, 3.44; N, 3.13 %. 
1-(2-Bromophenyl)-3-(4-fluorophenyl)-3-(phenylamino) 
propan-1-one (4m): Yellow solid, yield 77 %, m.p.: 
133−135 °C, Rf = 0.33. IR (KBr) vmax/cm
−1: 3397 (NH), 
1687 (C=O). 1H NMR (500 MHz, DMSO-d6), δ/ppm: 
3.35−3.46 (m, 2H, COCH2), 4.37 (s, 1H, NH), 5.00 (t, J 
= 6.50 Hz, 1H, NCH), 6.44−7.90 (m, 13H, ArH). MS 
(EI) m/z = 398 (M+, 17.10 %). Anal. Calcd. for 
C21H17BrFNO; MW = 398.27: C, 63.33; H, 4.30; N, 
3.52. Found C, 63.44; H, 4.80; N, 3.88 %. 
1-(2-Bromophenyl)-3-(4-fluorophenyl)-3-(4-fluoro-
phenylamino)propan-1-one (4n): Creamy solid, yield: 
77 %, m.p. 220−223 °C. Rf = 0.28. IR (KBr) vmax/cm
−1: 
3359 (NH), 1686 (C=O). 1H NMR (500 MHz, DMSO-
d6), δ/ppm: 3.33−3.41 (m, 2H, COCH2), 4.37(s, 1H, 
NH), 4.98 (t, J = 6.52 Hz, 1H, NCH), 6.42−7.99 (m, 
12H, ArH). MS (EI) m/z = 419 (M+ 3H) (38.9 %). Anal. 
Calcd. for C21H16BrF2NO; MW = 416.26: C, 60.59; H, 
3.87; N, 3.36. Found C, 60.88; H, 3.71; N, 3.23 %. 
The synthesis of the compounds (5a–e), yellow solids: 
Ar1= a) C6H5, b) C6H4-CH3-p, c) C6H4-Cl-p, d) C6H4-
Br-p, e) C6H4-Br-o has been described previously.
28−31 
 
General Method for Preparation of 5-(4-fluoro-
benzylidene)-2-thioxothiazolidin-4-one (6) 
A mixture of 4-fluorobenzaldehyde (2.0 mmol), 
Rhodanine (2.0 mmol), and SSA (0.11 g, 0.04 mol %) 
was stirred in EtOH (5 ml) at room temperature for 6 h. 
The reaction was monitored on TLC (.petroleum ether / 
ethyl acetate (4:1), Rf = 0.33. When the reaction com-
pleted, CH2Cl2 (5 ml) was added and catalyst was re-
moved by filtration. The Filtrate washed with saturated 
NaHCO3 (aqueous), brine and dried over anhydrous 
Na2SO4, filtered and the obtained clear filtrate evapo-
rated under reduced pressure to dryness. The obtained 
residue was purified by silica-gel chromatographic 
methods to obtain product (6) (yield 80 %). 
5-(4-Fluorobenzylidene)-2-thioxothiazolidin-4-one (6): 
Orange solid, yield 80 %, m.p.: 219−220°C.32 IR (KBr) 
vmax/cm
−1: 3424 (NH), 1698(C=O), 1189(S=O). 1H 
NMR (500 MHz, DMSO-d6), δ/ppm: 7.36−7.64 (m, 5H, 
ArH+ = CH), 13.83 (b, 1H, NH). MS (EI) m/z = 239 
(M+, 3.55). Anal Calcd. for C10H6FNOS2; MW = 
239.29: C, 50.19; H, 2.53; F, 7.94; N, 5.85. Found C, 
50.66; H, 2.40; F, 7.80; N, 5.65 %. 
 
General Method for Preparation of 2-(4-fluoro-
phenyl) benzothiazole (8) 
A mixture of 4-fluorobenzaldehyde (2.0 mmol), 2-
aminothiophenol (2.0 mmol), and SSA (0.11 g, 0.04 
mol %) was stirred in EtOH (5 ml) at room temperature 
for 7 h. The reaction was monitored on TLC (petroleum 
ether / ethyl acetate (4:1), Rf = 0.75. When the reaction 
completed; CH2Cl2 (5 ml) was added and the catalyst 
was removed by filtration. The obtained filtrate washed 
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with saturated NaHCO3 (aqueous), brine and dried over 
anhydrous Na2SO4, evaporated under reduced pressure 
to dryness. The obtained residue purified by silica-gel 
chromatography to give (8) (yield 85 %). 
2-(4-Fluorophenyl)benzothiazole (8): White solid, yield: 
85 %, m.p.: 98−100 °C.33 1H NMR (500 MHz, DMSO-
d6), δ/ppm: 7.17−8.13(m, 8H, ArH). MS (EI) m/z = 229 
(M+, 17.02 %). Anal Calcd. for C13H8FNS; MW = 
229.27: C, 68.10; H, 3.52; N, 6.11. Found: C, 68.22; H, 
3.42; N, 6.30 %. 
 
Anti-microbial Screening 
The anti-bacterial activity of the synthesized compounds 
was tested against two Gram- negative bacteria: Esche-
richia coli NCTC 10416, Pseudomonas aeruginosa 
NCIB 9016, and two Gram-positive bacteria: Bacillus 
subtilis NCIB 3610, Staphylococcus aureus NCTC 
7447, and one fungus namely: Candida albicans IMRU 
3669 using nutrient agar medium. 
 
Paper-disc Diffusion Technique 
A sterilized (autoclaved at 120 °C for 30 min) medium 
(40−50 °C) was incubated (1 ml/100 ml of medium) 
with the suspension (105 cfu ml−1) of the microorganism 
(matched to McFarland barium sulphate standard) and 
poured into a petri-dish to give a depth of 3–4 mm. The 
paper impregnated with the test compounds (µg/ml−1 in 
methanol) was placed on the solidified medium. The 
plates were pre-incubated for 1 h at room temperature, 
incubated at 37 °C for 24 and 48 hr for anti-bacterial 
and anti-fungal activities respectively. Ampicillin 
(mg/disc) was used as a standard for antibacterial and 
anti-fungal activity respectively. The observed inhibi-
tion zones are depicted in (Table 3). 
 
Conformational Search and Flexible Alignment 
Conformational analysis and flexible alignment of the 
tested compounds were carried out using the software 
(MOE34 of Chemical Computing Group Inc., on a Core 
2 duo 3.00 GHz workstation). The molecules were built 
by the builder module of MOE. The geometry opti-
mized using the MMFF94 force-field followed by a 
flexible alignment with systematic conformational 
search. Lowest energy aligned conformation(s) 
identified through the analysis module of DSV. 
 
RESULTS AND DISCUSSION 
In continuation of our studies on silica reagents,35−37 the 
present work was directed towards using silica sulfuric 
acid (SSA) catalyst for the synthesis of new β-amino 
carbonyls derivatives. Initial studies were performed 
between 4-fluorobenzaldehyde (1), acetophenones (2), 
and anilines (3) in the presence of this catalyst at room 
temperature (Scheme 1) and TLC plates monitored the 
reaction progress. 
For optimization, the reaction was carried out un-
der various conditions using different catalysts and 
solvents to probe the role played by SSA to find out the 
best catalyst and solvent as shown in Table (1). From 
the obtained results, the best catalyst and solvent in 
terms of yield and time was silica sulfuric acid (0.04 
mol) and EtOH (Table 1, entry 4). Therefore, EtOH 
(solvent) and SSA (catalyst) were used throughout the 
present study. 
Substrate scope investigations revealed that a vari-
ety of aromatic ketones 2 and amines 3 reacted smooth-
ly with 4-fluorobenzaldehyde 1 to afford the corre-
sponding β-amino fluorinated ketones (4a–n) and the 
aldol products (5a–e) (Scheme 1 and Table 2). 
From the obtained results, it was noticed that, both 
yield and reaction time depended on the nature of sub-
stituent. Thus, the presence of the electron-withdrawing 
group on the aromatic ketones (entry 10) increased the 
yield of β-amino ketones with reducing the reaction 
time (Table 2). Noteworthy to observe that when using 
aliphatic amines such as methylamine and n-butyl 
amine instead of aromatic amines under the same reac-
Table 1. Optimization of reaction conditions for the formation of representative compound (4a) 
Entry(a) Catalyst solvent Catalyst / mol % Time / h(b) Yield / %(c) Ratio (4a/5a) 
   1 SSA MeOH 0.04 14 55 57/43 
   2 SSA CH3CN 0.04 15 63 62/38 
   3 SSA CH2Cl2 0.04 16 60 55/45 
   4 SSA EtOH 0.04 13 80 70/30 
   5 SSA EtOH              0.1 13 50 20/80 
   6 SSA EtOH 0.02 14 65 60/40 
   7 FeCl3 EtOH 0.04 14 75 57/43 
   8 SiCl4 CH2Cl2 0.04 10 60 10/90 
   9 HClO4SiO2 EtOH 0.04 10 70 30/70 
 10 Me3ClSi EtOH 0.04   9 65 20/80 
(a) Reaction carried out in the appropriate solvent using 4-fluorobenzaldehyde (2 mmol), acetophenone (2 mmol) and aniline 
(2 mmol) at room temperature.  
(b) Detected by TLC.  
(c) Isolated yields after silica-gel chromatography. 
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tion conditions, the corresponding aldol condensation 
products (5a and c) were isolated as clean cut com-
pounds (100 % yield) without isolating the expected  
β-amino fluorinated ketones of type 4 (Scheme 2). 
A possible mechanism of the Mannich-type reac-
tion that involves the use of SSA as catalyst in ethanol 
is proposed (Scheme 3). When SSA was added to the 
reaction mixture, the carbonyl oxygen atom of the alde-
hyde becomes activated and this lead to formation of the 
intermediate I. Then, aniline (as a nucleophile) attacks 
the activated carbonyl group of benzaldehyde forming a 
hydrogen bond (between H and O) with SiO2-SO3H, 
affording the intermediate II with splitting of a water 
molecule through intramolecular rearrangement to the 
intermediate III. In the mean time the carbonyl oxygen 
atom of acetophone is activated by SSA, forming (enol 
form) intermediate IV. In the reaction medium, the  
π-electrons of the activated (or non-stabilized) imine 
delocalized towards the activated enol to form a new 
carbon-carbon bond through the reface of the double 
bond plane. The π-electrons of the activated enol re-
distribute to give keto form (accompanied by the trans-
fer of hydrogen atom to nitrogen atom). Finally, the 
Mannich adduct is formed and catalyst (SSA) renewed 
again (Scheme 3). 
The present work was continued to explore replac-
ing of acetophenone derivatives with other reagents. 
Thus, when the reaction was carried out using rhodanine 
under the same reaction conditions 5-(4-fluoro-
benzylidene)-2-thioxothiazolidin-4-one (6)38 (yield 80 %) 
was obtained as a sole product rather than the expected 
product 5-((4-fluoro-phenyl)(phenyl amino)methyl)-2-
thioxothiazolidin-4-one (7). Structure of product (6) was 
elucidated chemically by reacting rhodanine with 4-
fluorobenzaldehyde under the same reaction conditions, 
which gave the same product (m.p and mixed m.p.). Also, 
upon using 2-aminothiophenol instead of aniline deriva-
tives 2-(4-fluorophenyl)benzo-thiazole (8)39 (obtained as 
Scheme 1. One-pot synthesis of β-amino fluorinated carbonyl compounds (4a–n). 
Table 2. One-pot synthesis of β-amino fluorinated carbonyl compounds (4a–n) 
 Entry          2          3 4a–n 5a–e (a) 
Reaction (b)
Time / h 
    Ar1    Ar2    Ar1    Ar2 Yield / % Ar1 Yield / %  
   1 C6H5 C6H5 a) C6H5 C6H5 70 5a 30 13 
   2 C6H5 C6H4-CH3-p b) C6H5 C6H4-CH3-p 68 5a 32 11 
   3 C6H5 C6H4-F-p c) C6H5 C6H4-F-p 72 5a 28 11 
   4 C6H5 C6H4-Cl-p d) C6H5 C6H4-Cl-p 72 5a 28 12 
   5 C6H5 C6H4-Br-p e) C6H5 C6H4-Br-p 70 5a 30 12 
   6 C6H4-CH3-p C6H5 f) C6H5 C6H4-CH3-p 76 5b 33 15 
   7 C6H4-CH3-p C6H4-CH3-p g) C6H4-CH3-p C6H4-CH3-p 66 5b 34 13 
   8 C6H4-CH3-p C6H4-F-p h) C6H4-CH3-p C6H4-F-p 66 5b 34 13 
   9 C6H4-Cl-p C6H5 i) C6H4-Cl-p C6H5 87 5c 13   7 
 10 C6H4-Cl-p C6H4-F-p j) C6H4-Cl-p C6H4-F-p 90 5c 10   6 
 11 C6H4-Br-p C6H5 k)C6H4-Br-p C6H5 82 5d 18   8 
 12 C6H4-Br-p C6H4-F-p l) C6H4-Br-p C6H4-F-p 82 5d 18   8 
 13 C6H4-Br-o C6H5 m)C6H4-Br-o C6H5 77 5e 23 10 
 14 C6H4-Br-o C6H4-F-p n)C6H4-Br-o) C6H4-F-p 77 5e 23   9 
(a) 5a–e: Ar1= a) C6H5, b) C6H4-CH3-p, c) C6H4-Cl-p, d) C6H4-Br-p, e) C6H4-Br-o. 
(b) Stirring time at room temperature. 
 
Scheme 2. Reaction of methylamine or n-butyl amine with
4-fluorobenzaldehyde 1, aromatic ketones 2 in EtOH in pres-
ence of SSA at room temperature.  
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authentic sample from reaction of 2-aminothiophenol with 
4-fluorobenzaldehyde) was afforded (85 % yield) without 
isolation of the expected 3-(4-fluorophenyl)-3-(2-
mercaptophenylamino)-1-(4-sub-stitutedphenyl)-propan-
1-one (9) (Schemes 4 and 5). 
Unequivocal proofs for the role played by steric 
hindrance could come from the reaction of rhodanine 
and 2-aminothiophenol, which gave products (6) and (8) 
respectively as sole products. Structure of products (6) 




The synthesized β-amino ketones (4a–n), 5-(4-
fluorobenzylidene)-2-thioxothia zolidin-4-one (6) and 2-
(4-Fluorophenyl) benzothiazole (8) were tested for their 
in vitro antibacterial activity by using paper disc diffu-
sion technique.40−44 The tested microorganism strains 
were  (Gram-negative bacteria: Escherichia coli NCTC 
10416, Pseudomonas aeruginosa NCIB 9016 and 
Gram-positive bacteria: Bacillus subtilis NCIB 3610, 
 
Scheme 3. Proposed mechanism of the direct Mannich reaction catalysed by silica sulfuric acid. 
Scheme 4. Synthesis of 5-(4-fluorobenzylidene)-2-thioxothiazolidin-4-one (6). 
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Staphylococcus aureus NCTC 7447), Ampicillin was 
used as standard drug control. The results of antimicro-
bial activity values are furnished in (Table 3); and de-
picted graphically in (Figure 1). The data presented in 
(Table 3) cleared that, compound (4n) was the most 
active compound against all the tested bacterial strains; 
but compound (4m) was more potent against E. coli and 
S. aureus than the standard drug Ampicillin. Other syn-
thesized compounds showed weak activity and / or loss 
activity against the tested bacterial strains. 
 
Antifungal Activity 
The in vitro antifungal studies of all the synthesized com-
pounds (4a–n, 6 and 8) were tested against Candida 
albicans IMRU 3669, Ampicillin was used as reference 
drug and their inhibition zone diameter values were depict-
ed in (Table 3) and graphically in (Figure 1). In general, all 
the synthesized compounds exerted weak to inactive in 
vitro antifungal activity against all the tested organisms. 
Moreover, compounds (4m and 4n) were more effective 
against the tested fungus than the standard drug Ampicillin. 
Scheme 5. Synthesis of 2-(4-fluorophenyl)benzothiazole (8). 
Table 3. Anti-microbial activity of the synthesized compounds 
In vitro activity-zone of inhibition / mm (a) 
C. albicans P. aeruginosa S. aureus B. subtilis E. coli Comp No. 
─ ─ ─ ─ ─ 4a 
─ ─ ─ ─ ─ 4b 
─ ─ ─ ─ ─ 4c 
9 11 10 8 9 4d 
─ ─ ─ ─ ─ 4e 
─ ─ ─ ─ ─ 4g 
─ ─ ─ ─ ─ 4h 
─ ─ ─ ─ ─ 4i 
─ ─ ─ ─ ─ 4j 
10 8 8 8 9 4k 
─ ─ ─ ─ ─ 4l 
30 15 28 15 30 4m 
32 38 30 35 27 4n 
─ ─ ─ ─ ─ 6 
─ ─ ─ ─ ─ 8 
17 21 18 19 19 Ampicillin 
─ ─ ─ ─ ─ Chloroform 
(a) (-) Inactive (< 8 mm), weak activity (8-12 mm), moderate activity (12-15 mm), strong activity (> 15). 
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Structural Activity Relationship 
To obtained clear picture about the structure activity 
relationship (SAR) for the synthesized compounds, the 
target compounds were numbered (Figure 2). The ac-
tivity of the tested compounds must be correlated with 
structure modifications and variation. The obtained 
screening results showed that, compounds (4m and 4n) 
are the most active members. 
A close survey in vitro antibacterial and antifun-
gal activity profile of the new β-amino ketones against 
the tested bacterial and fungal organisms, gave a clear 
idea about the structure-activity correlations among 
the studied compounds. The presence of a fluo-
ropheny moiety (phenyl ring C) at N-11 with the 
presence of bromo substitution attached to phenyl ring 
(A) at the C-6 position compound (4n) exerted a sig-
nificant varied range of biological activities. In addi-
tion, the presence of bromine moiety at C-6 position 
(ring A) without substitution (ring C) showed signifi-
cant activity of compound (4n) against E.coli and C. 
albicans, which revealed moderate potency against 
other microorganisms. For comparison, compounds 
(4d and 4k), showed weak activity against all micro-
organisms and the other tested compounds do not 
show any activity against any microorganisms. Fur-
thermore, the observed marked antibacterial and anti-
fungal activities could be considered as key steps for 
the building of novel therapeutic compound with 
comparable pharmacological features with that of the 




Absorption, Distribution, Metabolism, Elimina-
tion(ADME) 
Toxic Factors Profiling 
Oral bioavailability considerably plays an important role 
for the development of bioactive molecules as therapeu-
tic agents. Several potential therapeutic agents fail to 
reach the clinic, because of ADME toxic Factors. There-
fore, a computational study for prediction of ADME 
properties of the molecules was performed for anti-
microbial compounds (4d, k, m and 4n), by the deter-
 
Figure 1. Antimicrobial activities of compounds (4a–n), (6) and (8) against bacterial strains (Gram negative and positive bacte-
ria), and fungal strain. 
 
Figure 2. A numbered target molecules (4a-4n).  
Table 4. Molecular parameters of the active compounds 
Compound* 4d 4k 4m 4n 
TPSA 29.1 29.1 29.1 29.1 
Log P 5.199 5.638 5.844 5.842 
nON 2 2 2 2 
nOHNH 1 1 1 1 
Lip-V 1 1 1 1 
Log S −5.52037 −5.95968 −6.31578 −6.31578
MR 9.46642 9.97162 10.24062 10.24062
* TPSA: Total Polar surface area, Log P: Calculated 
lipophilicity; nON: Number of hydrogen bond acceptor; 
nOHNH: Number of hydrogen bond donor; Lip-V: Number of 
violation from Lipinski’s rule of five; Log S: Solubility pa-
rameter; MR: Molar refractometry. 
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mination of topological polar surface area (TPSA), C 
log P and ‘‘rule of five’’ which have been formulated 
by Lipinski.45 The same author established that, a chem-
ical compound could be an orally active drug in hu-
mans, if no more than one violation of the following 
rule: i) C log P < 5, ii) number of hydrogen bond donors 
sites ≤ 5, iii) number of hydrogen bond acceptors sites ≤ 
10, iv) and molecular weight <500. In addition, the total 
polar surface area (TPSA) is another key property 
linked to drug bioavailability, the passively absorbed 
molecules with (TPSA>140) have low oral bioavailabil-
ity.46 Calculations were performed using MOE pro-
gram,47 the results were disclosed in (Table 4). The 
present results revealed that, the C Log P is the partition 
coefficient between water and octanol (factor of 
lipophilicity).48 Lipophilicity of most compounds is 
more than 5.0; the molecular weight (MW< 500), hy-
drogen bond acceptors between (1 and 2) and hydrogen 
bond donors (1) which fulfill Lipinski’s rule. These data 




In order to gain a better insight into the molecular struc-
tures of the active compounds (4m and 4n) and low 
active compounds (4d and 4k). The conformational 
analysis of the target compounds were performed using 
MMFF94 force-field49,50 (calculations in vacuum, bond 
dipole option for electrostatics, Polake Ribiere algo-
rithm, RMS gradient of 0.01 kcal/A mol) implemented 
in MOE 2009.10.). The most stable conformer was fully 
optimized by AM149 semi-empirical molecular orbital 
calculation (Figure 3). 
The calculation results showed that, the lowest 
minimization energy structures of the compounds under 
investigation exhibited a common arrangement and 
critical distance of the aryl moiety in (ring C) from the 
fluoropheny core (ring B). The optimal distance for the 
best biological activity was found in 3.12 Å and 3.13 Å 
for (4m and 4n) respectively, and the higher distance 
values in rang (3.16−3.18) lead to decrease in activity, 
as indicated in Figure 4. 
 
Flexible Alignment 
To understand similarity between the three-
dimensional structures of active compounds (4m and 
4n) a flexible alignment was employed (Figure 5), 
using MOE/MMFF94,50 and 200 conformers of each 
compound were generated and minimized with a dis-
tance-dependant dielectric model. A low energy set of 
100 was selected for further analysis. Conformations 
of compound (4m) were generated using distance 
geometry and optimized with MMFF94. Five low 
energy, maximally dissimilar structures were selected 
for comparison to the other compounds. After assign-
ing MMFF94 charges to all molecules, flexible align-
ment was ranked overlays of compounds (4m and 4n) 
based on electrostatic, steric filed, hydrophobic areas 
overlap, hydrogen bond acceptors and donors overlap. 
From the highest scoring superposition, the limited set 
conformers was used in the analysis for molecules 
with high flexibility capable for achieving complete 
atom-to-atom superposition (Figure 5a). A common 
feature of the MOE-generated alignments showed, 
comply of the two structures (4m and n) with: i) three 
phenyl rings (A, B and C), ii) COCH2NH spacer be-
tween rings (Figure 5a). With the same way, antimi-
crobial of compound (4n) and the lowest active com-
pounds (4d and 4k) were subjected to flexible align-
ments. Analysis of weak active molecules (Figure 5b) 
is an important way to gain clear vision of the essen-
tial features for a given activity. It is clear that com-
pounds (4d and 4k) were flexibly aligned in a differ-
ent manner when compared with the active compound 
Figure 3. Lowest energy conformers of the most active compounds (4m) and (4n) as representative examples in CPK rendering. 
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(4n). Common feature of the MOE-generated align-
ments showed, the superposition of the COCH2NH 
fragments in (4k) have a slight deviation (0.5 Å) 
compared with high active compound (4n), the three 
phenyl rings arrangement are in similar manner to all 
investigated compounds. These features explaining 
why such compound was the least active as antimi-
crobial agents and showing the importance of both 
COCH2NH moiety and the aromatic ring attached to it 
(Figure 5b). 
Electrostatic and Hydrophobic Mappings 
In an attempt to understand the lowest activity repre-
sented by (4k) and the highest antimicrobial activity 
represented by (4n), electrostatic and hydrophobic map-
pings was preformed for the lowest energy conformers, 
to examine the comply and incompliance in electronic, 
electrostatic binding characteristics of the surface of the 
molecules and conformational properties (Figure 6). 
First: comparison of the electrostatic mappings of low-
est active compounds, represented by compound (4k) 
Figure 4. 2D-pharmacophoric design of β-amino ketone (red colors represent the HB regions, green colors represent hydrophobic
regions and blue colors represent spacer moiety). 
Figure 5. Flexible alignments of the most active compounds (Left panel): 4d (in green), 4k (in red) and 4n (in blue). Right panel
showed flexible alignment of the high active compound 4n (in green) and lowest active compounds 4d (in red) and 4k (in blue). 
Kh. A. M. El-Bayouki et al., Highly Efficient One-pot Synthesis 265 
Croat. Chem. Acta 85 (2012) 255. 
(Figure 6a) showed common features: i) negative charge 
located on the carbonyl (in red), ii) non-polar area locat-
ed on the aryl moiety (in green), these features explain 
biological similarity among the low active analogues 
compounds. On the contrary, the high activity of com-
pounds (4m and n), represented by (4n, Figure 6) 
showed decrees distribution of negative charge (in red) 
on carbonyl group. From the above features, the low 
activity may be due to increasing negative charge locat-
ed on the carbonyl group region representing hydrogen 
bond acceptor (in red) (Figure 6a). As the same analogy, 
hydrophobic mappings of the most active compound 
(4n) showed that, the hydrophobic region (in green) was 
distributed on all sides of aromatic rings (A, B and C) 
while the hydrophilic region (in red) was located mainly 
on carbonyl fragments (Figure 6b). On the other hand 
the hydrophobic distributions of the inactive compounds 
(4k) occupying aromatic ring, indicating dissimilarity 
hydrophobic distributions of such compound (Figure 
6b). It is clear that the related charge distribution, elec-
trostatic and hydrophobic mappings suggest a similar 
interaction and orientations of the molecules with a 
potential protein-binding site. 
 
Pharmacophore Prediction 
The aim of this approach is generation and prediction a 
pharmacophore model (hypothesis) depending on the 
most active compound. These steps are employed for 
3D pharmacophore applications: i) Compound 4n (Fig-
ure 4) used as reference to other conformations of each 
compounds. ii) Assignment of the pharmacophoric 
features. ii) Application method for undertaking con-
formational searching of databases for new structures 
matching to generated pharmacophoric features. These 
steps will be explained (hypothetical) pharmacophoric 
building of antimicrobial compounds. Molecular Oper-
ating Environment (MOE) programme was used for 
pharmacophore building.51 The calculated conforma-
tional models were preformed with 15 kcal energy cut 
off (minimization convergence criteria during confor-
mational analysis: energy convergence = 0.01 kcal/mol, 
gradient convergence = 0.01 kcal/mol). The number of 
conformers generated for each substrate was limited to a 
maximum of 500. All molecules with their associated 
Figure 6. Electrostatic maps (left panels a) and hydrophobic panels (right panels b) of the lowest energy conformers for the most
active compounds (4n) and the least active compounds (4k); maps are color coded: red for the hydrogen bond and a hydrophilic
region, cyan for a medium polar region, and green for a hydrophobic region. 
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conformations were regrouped depending biological 
data. Hypothesis generation carried out with low energy 
conformers of the molecules. The calculation and analy-
sis were preformed. After assignment of possible 
pharmacophore elements for each analogue using MOE 
program, then superposition of the molecules including 
the assigned elements, was attempted (Figure 7), to 
generate Pharmacophore maps, many runs of calcula-
tion were repeated. For each run, a distinct number of 
specified pharmacophore elements were generated. All 
appropriate models showed that, the donor atoms of the 
NH fragments (as hydrophilic) element and the aryl 
moieties (as hydrophobic) were well superimposed 
within the set distance tolerance, which confirms the 
important role of the hydrophilic and hydrophobic 
moieties for antimicrobial activity. The initial 
pharmacophore query was carried out, and introducing 
of 5 features, as summarized in (Table 5) and illustrated 
graphically in (Figure 7). 
From (Figure 7a), Models for (4n) and its analogs 
(4m) possess pharmacophore elements in the aromatic 
(ring C) attached to NH group (as a hydrogen bond 
donor) which is out of plane with aromatic ring (B), 
which parallel with aromatic ring (A). In contrast, mod-
el for (4d) and its analogs (4k) (Figure 7b) showed 
common elements, the aromatic ring (B) coplanar with 
aromatic ring (A), and aryl amino part out of plane with 
aromatic ring (A) (Figure 7b). Since the arylamino- part 
of compound (4n) plays an important role in activity. 
According to the pharmacophore generated by MOE51 
the minimal structural requirements for antimicrobial 
activity consist of an aromatic ring (hydrophobic re-
Table 5. Pharmacophoric and structure features of the most 
active compounds 
Pharmacophoric features Structure features 
F1: Aro/Hydro Pheny and o-bromophenyl 
F2: Aro/Hydro p-florophenyl 
F3: Aro/Hydro Pheny and p-florophenyl 
F4: Acc C=O 
F5: Don NH 
 
Figure 7. a) Showed the best predicted pharmacophore features and geometries which are required for antimicrobial activity. b)
Showed the most active compounds 4m and 4n mapped to the pharmacophore model for antibicrobial activity. c) Showed the
lowest active compounds (4d and 4k) mapped to the pharmacophore model for antimicrobial activity. Pharmacophore features are
color coded: yellow for hydrophobic aromatics, cyane for a hydrogen bond donor, and blue for a hydrogen bond acceptor feature. 
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gion) attached to NH fragment (H-bonding donor re-
gion), and carbonyl fragment (H-bonding acceptor re-
gion) (Figures 4 and 7). This pharmacophoric assump-
tion was in consistence with biological data. 
 
CONCLUSIONS 
A facile and efficient one-pot three-component reaction 
between p-fluorobezaldehyde, selected acetophenone 
and several aniline derivatives, catalyzed by silica sulfu-
ric acid (SSA) for the synthesis of new β-amino carbon-
yl compounds (4) was investigated via Mannich reac-
tion to yield products (4) in good to excellent yields and 
in short time. Flexible alignment was conducted and 
justified the importance of the main molecular groups 
(particularly, the carbonyl fragment and the aryl rings 
(A and C) as well as of their relative distance. In fact, 
the substitution patterns on the phenyl ring (A or C) 
considerably affect the activity. The overall outcome of 
this model revealed that: i) the phenyl rings (A, B and 
C) are a satisfactory backbone for antimicrobial activity, 
(ii) the aryl (ring A) should be about less than 3.16 Å 
apart from the (ring C) (Figure 2). iii) Absence of bro-
mine as hydrophobic moiety at position 6 decreased the 
activity, such as 4-(fluoro, chloro and methyl) phenyl 
moiety, this indicted the importance of position 6 in the 
activity. These modeling studies could be very useful 
for the virtual screening in the development of the pres-
ently studied β-amino carbonyl compounds as antimi-
crobial agents. Therefore, the present work led to the 
development of novel antimicrobial agents especially in 
case of the two novel molecules (4m and 4n) for their 
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